Stock Market Watch

GlaxoSmithKline sells Penicillin Plants

by ·

Pharmaceutical giant GlaxoSmithKline (NYSE:GSK) has announced the sale of rights of its Penicillin products in United States to Indian pharmaceutical company Dr. Reddy’s (NYSE:RDY). GlaxoSmithKline (NYSE:GSK) will retain the right for the sold penicillin products for all the non U.S countries.

Dr. Reddy’s (NYSE:RDY) will also be getting a manufacturing plant owned by GlaxoSmithKline (NYSE:GSK) in Tennessee along with the entire penicillin portfolio. United States is the biggest market for GSK in terms of sales and profits. The rights include the popular products Amoxil and Augmentin. The deal will be completed by the first quarter of next year.

Related posts:

  1. GSK Gets Green Light For Lupus
  2. Haiti Cholera Outbreak
  3. Increasing Premature Deaths
  4. Bird Flu Resurfaces
  5. Finding The Source of HIV



Tags:

Ed Liston

Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications. He is widely quoted in various financial publications on the Internet. When Ed is not writing about stocks, investing in stocks, talking about stocks, or otherwise doing something stock related, he likes to go sailing and fishing.

You may also like...